International Biotechnology Trust as of March 31, 2021
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 56 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub SHS | 9.6 | $36M | 393k | 92.05 | |
| Gilead Sciences (GILD) | 6.6 | $25M | 388k | 64.62 | |
| Regeneron Pharmaceuticals (REGN) | 5.5 | $21M | 44k | 473.13 | |
| Neurocrine Biosciences (NBIX) | 5.3 | $20M | 207k | 97.22 | |
| Exelixis (EXEL) | 5.3 | $20M | 887k | 22.59 | |
| Ptc Therapeutics I (PTCT) | 5.1 | $19M | 408k | 47.35 | |
| Seagen | 4.9 | $19M | 133k | 138.83 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.8 | $18M | 85k | 214.84 | |
| Alnylam Pharmaceuticals (ALNY) | 4.1 | $15M | 109k | 141.18 | |
| Ionis Pharmaceuticals (IONS) | 4.0 | $15M | 334k | 44.95 | |
| Chemocentryx | 3.9 | $15M | 289k | 51.21 | |
| Biogen Idec (BIIB) | 3.6 | $14M | 49k | 279.75 | |
| Biohaven Pharmaceutical Holding | 3.2 | $12M | 176k | 68.35 | |
| Mirati Therapeutics | 3.1 | $12M | 67k | 171.16 | |
| Amgen (AMGN) | 2.8 | $11M | 43k | 248.81 | |
| Uniqure Nv SHS (QURE) | 2.5 | $9.5M | 282k | 33.65 | |
| Acceleron Pharma | 2.2 | $8.2M | 61k | 135.52 | |
| Turning Point Therapeutics I | 2.0 | $7.7M | 82k | 94.57 | |
| Incyte Corporation (INCY) | 1.7 | $6.3M | 78k | 81.27 | |
| Illumina (ILMN) | 1.7 | $6.3M | 16k | 384.05 | |
| Kalvista Pharmaceuticals (KALV) | 1.5 | $5.5M | 215k | 25.57 | |
| Deciphera Pharmaceuticals (DCPH) | 1.2 | $4.5M | 100k | 44.84 | |
| United Therapeutics Corporation (UTHR) | 1.2 | $4.4M | 27k | 167.26 | |
| BioMarin Pharmaceutical (BMRN) | 1.1 | $4.2M | 55k | 75.51 | |
| Protagonist Therapeutics (PTGX) | 1.0 | $3.9M | 152k | 25.90 | |
| Aurinia Pharmaceuticals (AUPH) | 1.0 | $3.9M | 299k | 12.98 | |
| Sutro Biopharma (STRO) | 0.8 | $3.2M | 139k | 22.76 | |
| Intra Cellular Therapies (ITCI) | 0.7 | $2.7M | 80k | 33.98 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.7 | $2.7M | 22k | 121.86 | |
| Sarepta Therapeutics (SRPT) | 0.6 | $2.3M | 32k | 74.54 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $2.3M | 20k | 113.68 | |
| Blueprint Medicines (BPMC) | 0.5 | $1.9M | 20k | 97.23 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $1.8M | 58k | 31.66 | |
| Allakos (ALLK) | 0.5 | $1.8M | 16k | 114.71 | |
| Ascendis Pharma AS Sponsored ADR (ASND) | 0.5 | $1.8M | 14k | 128.62 | |
| I Mab Sponsored Ads (IMAB) | 0.4 | $1.7M | 35k | 48.34 | |
| Sage Therapeutics (SAGE) | 0.4 | $1.6M | 22k | 74.84 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $1.5M | 60k | 25.78 | |
| Arena Pharmaceuticals | 0.4 | $1.5M | 21k | 69.38 | |
| Dyne Therapeutics (DYN) | 0.4 | $1.5M | 94k | 15.48 | |
| Halozyme Therapeutics (HALO) | 0.4 | $1.4M | 35k | 41.69 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $1.4M | 11k | 131.78 | |
| Nektar Therapeutics (NKTR) | 0.4 | $1.3M | 67k | 20.00 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $1.3M | 53k | 24.49 | |
| Insmed (INSM) | 0.3 | $1.1M | 34k | 34.05 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $1.1M | 22k | 51.53 | |
| Apellis Pharmaceuticals CM (APLS) | 0.3 | $1.0M | 23k | 42.78 | |
| Amicus Therapeutics (FOLD) | 0.2 | $935k | 95k | 9.88 | |
| Global Blood Therapeutics In | 0.2 | $888k | 22k | 40.73 | |
| Gamida Cell SHS (GMDA) | 0.2 | $862k | 107k | 8.06 | |
| Axsome Therapeutics (AXSM) | 0.2 | $793k | 14k | 56.64 | |
| Fibrogen (FGEN) | 0.2 | $684k | 20k | 34.72 | |
| Travere Therapeutics (TVTX) | 0.1 | $499k | 20k | 24.95 | |
| Bluebird Bio (BLUE) | 0.1 | $332k | 11k | 30.18 | |
| Esperion Therapeutics (ESPR) | 0.1 | $266k | 9.5k | 28.00 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $216k | 10k | 21.60 |
